New French LNG terminal at Le Havre receives first cargo: S&P Global data | S&P Global Commodity Insights
![NEW DELHI, INDIA - NOVEMBER 7: Prime Minister of India Narendra Modi with King Philippe of Belgium during the delegation meeting at Hyderabad House on November 7, 2017 in New Delhi, India. NEW DELHI, INDIA - NOVEMBER 7: Prime Minister of India Narendra Modi with King Philippe of Belgium during the delegation meeting at Hyderabad House on November 7, 2017 in New Delhi, India.](https://c8.alamy.com/comp/2EW9309/new-delhi-india-november-7-prime-minister-of-india-narendra-modi-with-king-philippe-of-belgium-during-the-delegation-meeting-at-hyderabad-house-on-november-7-2017-in-new-delhi-india-king-philippe-and-queen-mathilde-of-belgium-arrived-in-new-delhi-on-a-seven-day-visit-to-india-with-an-aim-at-boosting-overall-cooperation-between-the-two-countries-with-a-focus-on-further-ramping-up-trade-and-investment-ties-he-is-accompanied-by-a-business-delegation-of-nearly-90-people-comprising-ceos-of-belgian-companies-india-is-belgiums-second-largest-export-destination-and-third-largest-trade-partne-2EW9309.jpg)
NEW DELHI, INDIA - NOVEMBER 7: Prime Minister of India Narendra Modi with King Philippe of Belgium during the delegation meeting at Hyderabad House on November 7, 2017 in New Delhi, India.
![Belt Buckle MET dp30378 465454 Frankish, Belt Buckle, 6th?7th century, Iron, silver inlay, Overall: 5 13/16 x 2 11/16 x 1 1/16 in. (14.7 x 6.8 x 2.7 cm). The Metropolitan Museum Belt Buckle MET dp30378 465454 Frankish, Belt Buckle, 6th?7th century, Iron, silver inlay, Overall: 5 13/16 x 2 11/16 x 1 1/16 in. (14.7 x 6.8 x 2.7 cm). The Metropolitan Museum](https://c8.alamy.com/comp/KNYJ54/belt-buckle-met-dp30378-465454-frankish-belt-buckle-6th7th-century-KNYJ54.jpg)
Belt Buckle MET dp30378 465454 Frankish, Belt Buckle, 6th?7th century, Iron, silver inlay, Overall: 5 13/16 x 2 11/16 x 1 1/16 in. (14.7 x 6.8 x 2.7 cm). The Metropolitan Museum
![North American Phase 3/3b Experience With Long-Acting Cabotegravir and Rilpivirine: Efficacy, Safety, and Virologic Outcomes North American Phase 3/3b Experience With Long-Acting Cabotegravir and Rilpivirine: Efficacy, Safety, and Virologic Outcomes](https://www.natap.org/2021/images/100121/100121-7/1001211.gif)